В.Л. Лобашова, А.П. Шепелькевич
ГУ «Республиканский центр медицинской реабилитации и бальнеолечения», УО «Белорусский государственный медицинский университет»
Жировая ткань в настоящее время рассматривается как эндокринный орган, которому свойственны аутокринные и паракринные свойства. Резистин - протеин, открытый в 2001году, относится к классу богатых цистеином белков, физиологическая роль которого по сей день является предметом многочисленных исследований.
ключевые слова: молекула резистина, инсулинорезистентность, гормон, адипоцит
The molecule resistin: structure, biological role
V.L. Lobashov, A.P. Shepelkevich
Fat tissue is currently considered to be an endocrine organ, which is characterized by its autocrine and paracrine properties. Discovered in 2001 the hormone resistin belongs to the group of cysteine-rich proteins which biological role is still the subject of numerous studies of scientists all over the world.
keywords: resistin molecule,insulin resistance, hormone, adipocyte
1. Клинико-патогенетическое значение резистина сыворотки крови при остеоартрозе / Д.А.Попов [и др.] //Медицинский вестник Северного Кавказа.-2012.-№ 2.- С.54-57.
2. Adeghate, E. An update on the biology and physiology of resistin / E. Adeghate // Cell Mol Life Sci.- 2004.-№61(19-20).-Р.2485-2496.
3. The hormone resistin links obesity to diabetes / СM Steppan [et al.] // Nature. -2001.- №409(6818).- Р.307–312 .
4. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation / KH Kim[et al.] // J Biol Chem.- 2001.- №276 (14).-Р.11252–11256.
5. A family of tissue-specific resistin-like molecule / СM Steppan [et al.] // Proc Natl Acad Sci U S A.- 2001.-№98(2). -Р.502-506.
6. Hannan, F Human resistin and the RELM of Inflammation in diabesity / F Hannan and K Culligan // Diabetol Metab Syndr.- 2015.- №7(54).
7. The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications / S Ghosh[et al.] // Gene .-2003.-№ 305.Р. 27–34 .
8. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family / IN Holcomb [et al.] // EMBO J. -2000.-№ 19.-Р.4046–55.
9. Resistin-like molecule-β (RELM-β) targets airways fibroblasts to effect remodelling in asthma: from mouse to man / C. L. Fang [et al.] // Clin Exp Allergy.- 2015 .- № 45(5).-Р. 940–952,
10. Absence of bacterially induced RELM-beta reduces injury in the dextran sodium sulfate model of colitis / LD McVay [et al.] // J Clin Invest.-2006.-№116.- Р.2914–2923.
11. Resistin: A Potential Biomarker for Periodontitis Influenced Diabetes Mellitus and Diabetes Induced Periodontitis / A Devanoor [et al.] // Disease Markers- 2014.
12. Инновационные технологии для лабораторной диагностики и научных исследований [Электронный ресурс]. - Режим доступа: https:// biochemmack.ru/catalog/element / 14118/ 40501/.- Дата доступа: 24.06.2017.
13. Disulfide-Dependent Multimeric Assembly of Resistin Family Hormones S D. Patel [et al.] // Science.- 2004.-№304(5674).- Р.1154-1158.
14. Kusminski, CM Role of resistin in obesity, insulin resistance and Type II diabetes / CM Kusminski 1, PG McTernan , S Kumar // Clin Sci (Lond).- 2005.- №109(3).- Р.243-256.
15. Resistin: functional roles and therapeutic considerations for cardiovascular disease / Md S Jamaluddin[et al.] //Br J Pharmacol.- 2012.- №165(3).- Р 622–632.
16. Lipid metabolism and resistin gene expression in insulin-resistant Fischer 344 rats / J. R. Levy [et al.] // Am. J. Physiol. Endocrinol. Metab. -2002.- №282.- Р.626–633.
17. Increased resistin gene and protein expression in human abdominal adipose tissue / McTernan [et al.]// J. Clin. Endocrinol. Metab.-2002.-№ 87.
18. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators / L Patel [et al.]// Biochem Biophys Res Commun.- 2003.- № 300.-Р.472–476.
19. Resistin release by human adipose tissue explants in primary culture / JN Fain [ et al] // Biochem Biophys Res Commun.- 2003.- № 300.-Р.674–678.
20. High resistin and interleukin-6 levels are associated with gestational diabetes mellitus / M Kuzmicki[ et al] // Gynecol Endocrinol.- 2009.- №4.- Р.258-263.
21. Клебанова Е.М. Гормоны жировой ткани и их роль в патогенезе СД 2 типа / Е. М. Клебанова, М. И. Балаболкин //Лечащий врач.-2010.-№11.
22. Сentral Resistin Overexposure Induces Insulin Resistance Through Toll-Like Receptor4 / Y Benomar [et al] // Diabetes.- 2013.- № 1.-Р.102-114.
23. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4 / A Tarkowski [ et al] //J Cell Mol Med.- 2010.-№6.-Р.1419-1431.
24. ШВАРЦ, В.Я.Воспаление жировой ткани (часть 4).Ожирение-новое инфекционное заболевание (обзор литературы)/ В.Я.Шварц // Проблемы эндокринологии.- 2011.
25. Rajala, MW Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting / MW Rajala,Qi , H .R Patel // Diabetes.-2004.- 53.-Р.1671–1679.
26. Increased Insulin Sensitivity in Patients with Anorexia Nervosa: The Role of Adipocytokines / I Dostalova [ et al] // Physiol Res. – 2007.- №56(5).- Р.587-594.
27. Obesity, inflammation, and periodontal disease / N Pischon[ et al] // Journal of Dental Research. -2007.-№86(5).-Р.400–409.
28. Vendrell, J Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity/ J Vendrell, M Broch, N Vilarrasa // Obes. Res.-2004.-№ 12.-Р.962–971.
29. Degawa-Yamauchi, M Serum resistin (FIZZ3) protein is increased in obese humans/ М Degawa-Yamauchi, J. E Bovenkerk, B. E Juliar // J. Clin. Endocrinol. Metab. -2003.- №88.-Р.5452–5455.
30. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans / Utzschneider KM [et al.] // Diabetologia. – 2005.-№48(11).-Р.2330–2333.
31. Mechanisms of fatty acid-induced inhibition of glucose uptake / G Boden [et al.] // J. Clin. Invest. - 1994. -№ 93.- Р. 2438-2446
32. Role of resistin in diet-induced hepatic insulin resistance / ED Muse [et al.] // J. Clin. Invest. - ‎2004.- №114(2).-Р.232-239.
33. Changes in glycemia by leptin administration or high-fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis / С Asensio [et al.] // Endocrinology.-2004.-№145.-Р.2206–2213.
34. Harris, RE Inflammation in the Pathogenesis of Chronic Diseases: The COX-2 Controversy / Randall E. Harris.-USA,Columbus:Springer,2007.-322p.
35. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance / MJ Bahr [et al.] //Am J Physiol Endocrinol Metab .- 2006 .- №291.- Р.199 –206.
36. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa / Housová [et al.] // J Clin Endocrinol Metab. -2005.-№90(3).-Р.1366-1370.
37. Central and Peripheral Peptides Regulating Eating Behaviour and Energy Homeostasis in Anorexia Nervosa and Bulimia Nervosa: A Literature Review/ A Tortorella [et al.] // European Eating Disorders Review.- 2014.- №22(5).
38. .Данилова, Л.И Феномен инсулинорезистентности в клинической практике: механизмы формирования и возможности коррекции / Л.И.Данилова.- Минск;БелМАПО,2013.
39. Гормоны жировой ткани и функциональная активность щитовидной железы / Н.А.Петунина [ и др.] // Ожирение и метаболизм .-2010. -№4.
40. Resistin is an inflammatory marker of atherosclerosis in humans / M. P. Reilly [et al.] //Circulation.-2005.-№ 111.-Р.932–939.
41. Влияние резистина на течение ИБС у пациентов с СД 2 типа / А.Т Тепляков [и др.] // Бюллетень сибирской медицины.- 2015.-№14(5).- С.73-82.
42. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer/ TE Nakajima [et al.] J Gastroenterol. – 2009.- №44(7).-Р.685–690.
43. Relationship of resistin levels with endometrial cancer risk/ M Hlavna [et al.] // Neoplasma.- 2011.-№ 58(2).-Р.124–128.
44. Hyperresistinemia is associated with postmenopausal breast cancer/ M Dalamaga [et al.] // Menopause.- 2013.-№20(8).- Р.845–851.

Поступила 9.10.2017 г.
Формат файла: pdf (395.31 Кб)